Kim, Y.-S., Lee, S.-H., Park, A. H., Wu, C., Hong, B.-K., Jung, H., Lin, S. H., Yoo, S. S.

Background
While Programmed cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) blockade is a potent antitumor treatment strategy, it is effective in only limited subsets of patients with cancer, emphasizing the need for the identificat…